Retraction

miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.3233/TUB-219010
Additional Notes:

see also: https://pubpeer.com/publications/07999850A66A7387150AC933717210

Citations (31)

31
Total Citations
3
Post-Retraction
(9.7%)
28
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
3 Within 1 year
0 After 2+ years
163 Days since retraction (latest)
The Interrelationship Between FYN and miR-128/193a-5p/494 in Imatinib Resistance in Prostate Cancer
Sercan Ergün, Oğuzhan Akgün, Neslihan Hekim et al. (7 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Jun 2022
3 citations
163 days after retraction
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine
Amoolya Kandettu, Divya Adiga, Vasudha Devi et al. (7 authors)
Genes & Diseases Open Access
Published: Mar 2022
15 citations
70 days after retraction
Combination of anticancer drugs with microRNA as cancer therapeutics
Smruti Rekha Rout, Gowtham Kenguva, Vanshikha Singh et al. (6 authors)
Elsevier eBooks
Published: Jan 2022
11 days after retraction
MicroRNA-494-3p inhibits formation of fast oxidative muscle fibres by targeting E1A-binding protein p300 in human-induced pluripotent stem cells
Hirotaka Iwasaki, Yoshinori Ichihara, Katsutaro Morino et al. (11 authors)
Scientific Reports Open Access
Published: Jan 2021
5 citations
342 days before retraction
Long noncoding RNA FTX ameliorates hydrogen peroxide-induced cardiomyocyte injury by regulating the miR-150/KLF13 axis
Yamin Zhang, Xiaoying Fan, Hua Yang
Open Life Sciences Open Access
Published: Dec 2020
12 citations
355 days before retraction
Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
Ali A. Alshamrani
Frontiers in Oncology Open Access
Published: Jul 2020
77 citations
518 days before retraction
Insulin‐Like Growth Factor and Insulin‐Like Growth Factor Receptor Expression in Human Idiopathic Autism Fusiform Gyrus Tissue
Milena Cioana, Bernadeta Michalski, Margaret Fahnestock
Autism Research
Published: Mar 2020
15 citations
651 days before retraction
MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells
Pei‐Ling Hsieh, Yi‐Wen Liao, Martin Pichler et al. (4 authors)
Cancers Open Access
Published: Feb 2020
15 citations
687 days before retraction
MicroRNA delivery through nanoparticles
Sharon Wei Ling Lee, Camilla Paoletti, Marco Campisi et al. (8 authors)
Journal of Controlled Release Open Access
Published: Oct 2019
341 citations
798 days before retraction
Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy
Daniel F. Costa, Vladimir P. Torchilin
Biomedical Microdevices
Published: Jul 2018
23 citations
1258 days before retraction
miR‑494‑BAG‑1 axis is involved in cinobufacini‑induced cell proliferation and apoptosis in gastric cancer
Zhili Shen, Yan Li, Chengcheng Zhao et al. (6 authors)
Molecular Medicine Reports Open Access
Published: Mar 2018
15 citations
1372 days before retraction
Potential tumor suppressing role of microRNA-545 in epithelial ovarian cancer
Xibiao Jia, Xiaogang Liu, Ming Li et al. (9 authors)
Oncology Letters Open Access
Published: Feb 2018
17 citations
1393 days before retraction
Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST
Juozas Kupčinskas
International Journal of Molecular Sciences Open Access
Published: Jan 2018
12 citations
1421 days before retraction
Development of novel oligonucleotide therapeutic molecules targeting microRNAs for tackling brain cancers
Leon M. Larcher
Unknown Journal
Published: Jan 2018
1450 days before retraction
miR-455-3p functions as a tumor suppressor in colorectal cancer and inhibits cell proliferation by targeting TPT1.
Yuanyuan Sun, Yan Wang, Hainan Yang et al. (5 authors)
PubMed
Published: Jan 2018
13 citations
1450 days before retraction
Upregulation of miR‑598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression
Kunping Li, Yongping Fang, Jinqi Liao et al. (7 authors)
Molecular Medicine Reports Open Access
Published: Dec 2017
22 citations
1476 days before retraction
Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis
Zhenxian Xiang, Min Sun, Zewei Yuan et al. (7 authors)
Oncotarget Open Access
Published: Nov 2017
5 citations
1509 days before retraction
Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia
Çağla Kayabaşı, Tuğçe Balcı Okcanoğlu, Besra Özmen Yelken et al. (8 authors)
Gene
Published: Sep 2017
14 citations
1553 days before retraction
MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer
Yanli Wang, Jia Li, Chunling Xu et al. (4 authors)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics Open Access
Published: Jun 2017
30 citations
1638 days before retraction
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
Simona Salati, Valentina Salvestrini, Chiara Carretta et al. (19 authors)
Oncotarget Open Access
Published: May 2017
52 citations
1688 days before retraction
Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury
Shixin Gu, Rong Xie, Xiaodong Liu et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Apr 2017
116 citations
1725 days before retraction
MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.
Lin Yang, Yang Jin, Tianmin Xu et al. (5 authors)
PubMed
Published: Jan 2017
29 citations
1815 days before retraction
MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.
Yu-Chun Wang, Cong Xu, X Zhang
PubMed
Published: Jan 2017
31 citations
1815 days before retraction
The functional consequences and prognostic value of dosage sensitivity in ovarian cancer
Zichuang Yan, Yongjing Liu, Yunzhen Wei et al. (8 authors)
Molecular BioSystems
Published: Dec 2016
10 citations
1838 days before retraction
MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications
Yu Ma, Yan Lü, Bingjian Lü
Cancer Investigation
Published: Sep 2016
15 citations
1911 days before retraction
MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination—what we learned from microRNA-494
Margarita González‐Vallinas, Kai Breuhahn
HepatoBiliary Surgery and Nutrition Open Access
Published: Jun 2016
9 citations
2013 days before retraction
Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health
Víctor Micó, Laura Díez-Ricote, Lidia Daimiel
International Journal of Molecular Sciences Open Access
Published: Feb 2016
25 citations
2125 days before retraction
MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc
Jialing Yuan, Kana Wang, Mingrong Xi
Medical Science Monitor Open Access
Published: Feb 2016
43 citations
2127 days before retraction
miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.
Hang Tian, Lei Hou, Yumei Xiong et al. (7 authors)
PubMed
Published: Jan 2016
39 citations
2181 days before retraction
MicroRNA-494 inhibits proliferation and metastasis of osteosarcoma through repressing insulin receptor substrate-1.
Xiaodong Zhi, Kai Wu, Deshui Yu et al. (7 authors)
PubMed
Published: Jan 2016
24 citations
2181 days before retraction
miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.
Bai Li, Liang Ge, Minghe Li et al. (5 authors)
PubMed
Published: Jan 2016
37 citations
2181 days before retraction
Quick Stats
Total Citations: 31
Years Since Retraction: 3.9 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers